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Connected Health: An Open Innovation Perspective

Anushree Priyadarshini*a, Maria Quinlana, and Gerardine Doylea
a

Applied Research for Connected Health (ARCH) and UCD College of Business, University College Dublin,
Belfield, Dublin 4, Ireland
Abstract: The concept of connected health has gained traction in recent years as a new technology enabled and
networked model of healthcare delivery. It is often used as an umbrella term for eHealth, digital health, health
informatics, telemedicine, mHealth and involves the establishment and management of a network of stakeholders
with the aim of improving healthcare quality and outcomes. Yet a lack of open interactions and knowledge
networks and the missing integration of the larger constituency of interdisciplinary experts are limiting the
execution of the model and restricting its potential to devise services and interventions around patient’s needs with
shared health related data. Drawing parallels between the concept of connected health and open innovation, the
networked innovation model, which involves efficient management of knowledge flows and complex networks for
successful innovations; in this paper we outline the practice of open innovation in healthcare and suggest
connecting stakeholders in the healthcare ecosystem in an open innovative format. In doing so we present a
categorization of firms in the healthcare ecosystem into open innovation profiles for becoming connected and
propose an open innovative framework for maximizing the potential of the concept of connected health.
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1. INTRODUCTION
The phenomenon of increasingly networked process of
innovation in which companies profit from external
knowledge is called ‘open innovation’, a paradigm that
assumes that organizations can and should combine internal
ideas, external ideas and paths to market, as they look to
advance their technologies [1]. Advantages of this strategy
are that firms can make use of pooled human resources,
technology and customer information. These can result in
speeding up the innovation process, spreading the risk of
innovation failure, reducing the costs of technological
development or market entry and improving the achievement
of economies of scale in production. This apparently new
paradigm, involves efficient management of knowledge
flows and complex networks for successful innovations [2,
3].
The concept overlaps well with the diverse features of
‘connected health’. Indeed, the range of complex
stakeholders, technologies, objectives and disciplines
involved in connected health tend to exponentially increase
its heterogeneity and calls for the establishment and
management of networks, similar to that which is required in
an open innovation scenario. Pagilari [4] and Dooris [5]
suggest that the potential of connected health may be
maximized by the involvement of a wider community of
disciplinary experts, including managers and accountants,
social scientists and legal experts. While it can be argued that
even though not currently strategically rolled out in practice,
the open innovation approach forms the premise for the
concept of connected health to fully flourish [6]. Examples
like GSK and the Hammersmith Hospital’s collaboration for
a Clinical Imaging Centre; NHS Trusts in Scotland and
Wyeth Pharmaceuticals’ Experimental Medicine project are
fast growing [7]. Yet as outlined by Eaton [8] it is
noteworthy that the lack of open interactions and knowledge
XXX-XXX/14 $58.00+.00

networks and the missing integration of the larger
constituency of interdisciplinary experts are increasingly the
underlining factor for a missing open innovative framework
in the healthcare system. Similarly, Brodie [6] also suggests
that the size, level of complexity of the organization,
difference in attitudes of the partners and lack of any rewards
limit the collaborative opportunities in the healthcare arena.
Therefore as an approach for players in the healthcare
landscape to be connected, in this paper firstly we propose a
categorization for firms who operate within the healthcare
ecosystem into open innovation profiles for becoming
connected. Secondly we propose an open innovative
framework for the implementation of connected health.
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2. OPEN INNOVATION IN HEALTHCARE
Healthcare research is under increasing pressure to
innovate in order to counter rising operational costs and
depleting pipelines [9]. While currently the focus of
innovation in healthcare is on patient care and disease
mitigation [10]; demographic changes, advancements in
medical science, major scarcities of human and financial
resources and the increasing empowerment of users is fast
resulting in a paradigm shift towards prevention,
participation and coaching [11]. This is essentially a move
from merely looking at healthcare via the biomedical lens of
diagnosis and treatment, towards a more holistic social
model of healthcare which incorporates a person’s wider
social and cultural factors. Boote et al. [12] argue that for the
advancement of research and development in health care, it
© 2014 Bentham Science Publishers
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is crucial to integrate the users in health and social research.
Supporting this stance Dahlander and Gann [13] also suggest
that although traditionally integration of users in health care
research was marred by significant costs, advancing
technologies and usage behaviors today suggest that the
integration of users into innovation activities has become
quite feasible and cost-effective.
Open innovation is increasingly touted as the business model
for growing value and innovation through partnership. The
concept, in which organizations collaborate on research with
users and other external partners, is progressively showing
strong potential to contribute to improvements in the quality
of healthcare innovation and delivery [7]. While it is gaining
traction in the form of typologies like clinicians forming a
network for healthcare innovation (example: The Society of
Physician Entrepreneurs) and as public health systems
encouraging digital health companies to engage with them
(example: eHealth Connect, Ireland), the key application of
open innovation in healthcare currently has been
experimental medicine via patients as innovators [14]. In this
approach, academic researchers, clinicians and industry
collaborate with patients for developing healthcare
innovations. Another avenue has been identification and
collaboration with persons who suffer from a health problem
and independently develop solutions for it [14]. For instance,
in 2004 a British process engineer, Tal Golesworthy,
diagnosed with Marfan syndrome, designed his own heart
textile implant when he realized it was better than an aortic
valve replacement. His ‘lay’ solution has been implanted in
23 other people since then [15]. Another example is that a
mother of a young woman with vaginal adenocarcinoma who
explored and suggested that the cause of the disease might
have been diethylstilboestrol; the mother of another patient
was the first to hypothesize that a low maternal serum
(alpha) fetoprotein concentration might be a marker for
trisomy [16]. These examples reinforce the significance of
integrating users in health care research.
Thus far, integrating the users/care givers in healthcare
research has largely been limited to the incorporation of
patients in the reviewing and testing stage of the research
and development process [12]. However, there is an
increasing need to move beyond blockbuster drugs and to
renew the focus on medicines and diagnostics so that smaller
groups of patients with specific unmet needs can be targeted.
Merging technology with biology is required so that the
collection, analysis and sharing of data can result in
developing clinical insight relating to patient care and
response to treatments. Having a range of funding sources,
including from research councils to commercial entities is
needed and patients must be empowered so that they strive
for greater participation in decisions relating to the choice of
their treatment and care. Therefore, further to the just user
collaboration, a more integrated approach in the healthcare
sector is called for, a connected health approach, that aligns
healthcare providers with industry, with caregivers, patients
and payers to integrate multiple healthcare solutions [7].
Given the current technological developments, especially the
convenience of interactive web-based technologies that
enable active participation of a wider group of stakeholders,
this can be achieved by a culture change in healthcare and
close collaboration between healthcare, industry and
regulatory stakeholders in an open innovative model [17].
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To connect stakeholders in the healthcare ecosystem for an
open innovative format, it is essential to first categories
companies based on their business needs and the different
innovation strategies [18]. The classification can assist
mapping firms based on their business efficiencies and value
so that it can be identified to whom firms must open, within
and across categories for successful connections.
To adapt to the unprecedented change in the healthcare
industry, firms are adopting different innovation strategies to
offer healthcare solutions [19], and based on these the
companies can be categorized as follows:
Products based: firms that develop product or services and
progress along the drug development process. These firms
generate value by either licensing their products to
pharmaceutical companies or by commercializing them.
Platforms based: firms that are engaged in improving
processes and developing new capabilities, internally or
through collaborations.
Technology based: firms that develop new technologies for
all aspects of healthcare.
Hybrid: firms that are engaged in innovating revenue
generation, moving from sales of drugs, diagnostics or
devices. These focus on combining technology and platforms
with services and the creation of products.
Growing complexities, advanced technologies and easy access
to highly qualified experts that are outside the confines of the
companies, alongside with mounting pressure on time and cost
is rapidly advancing the development of open innovation in
the healthcare industry. For example, pioneering the concept,
Eli Lilly as early as in 2002, established networks of the global
pharmaceutical companies [20], namely the Fully Integrated
Pharma Network, the Phenotypic Drug Discovery Initiative,
the Target Drug Discovery Initiative and Chorus for
collaborative research [21]. In 2007, GlaxoSmithKline (GSK)
launched its Centre for Excellence for External Drug
Discovery, for complete focus on drug discovery alliances
with external partners [22]. Similarly reducing its R&D budget
Pfizer in 2010, established Centers for Therapeutic Innovation,
with an aim to develop global partnerships between Pfizer and
academic medical centers [23]. While elements of a more
open business model for pharmaceutical R&D are increasingly
becoming evident [24], the approach has not been adopted to
harness open interactions beyond R&D projects where
healthcare companies are accessing external knowledge either
to manage limited development times and costs, or for getting
external information and know-how that companies do not
have. Open innovative interactions amongst all players in the
healthcare ecosystem and development of knowledge
networks based upon profiling of firms as outlined above can
result in the integration of the larger constituency of
interdisciplinary experts and can be the underlining factor in
implementing connected health with an open approach.
4. OPEN INNOVATION
CONNECTED HEALTH

FRAMEWORK

FOR
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While drawing open innovation profiles for firms in the
healthcare sector forms the starting point of an open
approach to connected health, connecting these firms with
other stakeholders in the ecosystem calls for an
understanding of the requirements of the concept to build
solutions. In this vein it can be envisaged that the demand
side of developing connected health solutions on the ground
involves several factors. These include creating a patient’s
health record; building a lifelong health history for a patient
from information held in multiple, diverse systems; joining
the different systems on different platforms; interconnecting
diverse systems so that they can interoperate; developing
communication between remote systems and achieving
performance and scalability [25]. Thus working from the
requirements towards solutions, taking into consideration the
current as well as the required perspectives of the
stakeholders, an open connected health model that involves
engaging with different parties, is suggested (Fig. 1).

Fig. 1. An open interactive connected health model.

of the health system. Patients need to become more involved
in order to better track and manage their health by using
tools that are outside of traditional medical settings,
leveraging the formal healthcare system information to
advance their engagement with their circle of care; and
services between care providers (hospitals, clinics and third
parties such as home-care providers and informal care
providers) to be coordinated through connectivity, allowing
for seamless collaboration.
Implementation of this open collaborative approach in
healthcare, like in other industries requires focusing on the
operational and ownership complexities [24]. These call for
firstly exploring the existing openness amongst the different
players in the ecosystem as against the connected
framework. This is to be followed by conducting a gap
analysis and then designing the execution plan which could
take different routes. For example routes like strategically
driven, top-down centralized approach common in fast
moving consumer goods (FMCG) organizations where the
market is demanding with high competition and achieving
revolutionary innovations is difficult [26]; or strategically
driven, distributed approach as is followed by energy
companies that in small groups make contacts with potential
partners for collaboration [27]. Other routes could be bottom
up evolutionary approaches, either centralized or distributed,
that are driven by environmental conditions like market
forces as in the case of the telecommunications industry [28].
Similarly managing the ownership complexities of
implementing an open collaborative approach in healthcare
requires exploring the influence of the network participants
on getting connected and their flexibility around the outcome
of participation. Attitudes may vary amongst partners about
intellectual property (IP) rights [6]. Also misconceptions that
open innovation underrates and weakens IP protection may
limit the collaborative approach. Based on the scenario of
these complexities, agendas and directions can be designed.
Like defining at the onset of the collaboration the ownership
and legal rights if an IP is jointly created. How value will be
derived by using IP for increasing returns and if goals and
milestones of the collaboration are not met, identifying what
would be the potential exit strategies [29].
5. LIMITATIONS AND RECOMMENDATIONS

The framework outlines that for the healthcare system to be
integrated and interactive at multiple levels and for open
interactive connected health to become a reality, continuous
interoperable health data must flow between patients and
their care providers bi-directionally in real time. This can be
achieved by creating an access portal that acquires and
integrates the data in collaboration with the different players
in the ecosystem. The key elements required here include
ensuring access, collection and sharing of information across
parties; for pharmaceutical firms to work in collaboration
with patients, care providers and amongst themselves to
create platforms to achieve digitalization and connectedness

Apart from operational and ownership complexities,
limitations to achieving a fully connected health care system
include need for changing workflows and processes. As
these tend to be engrained in organizational working,
adopting an open connected health model that involves
aligning with other organization’s cultures and strategies can
be quite a limiting factor [29]. The sheer size and complexity
of certain partners including their bureaucratic imperatives
may also limit collaborative opportunity [6].While personal
career priorities and cultural resistance from the healthcare
professionals may inhibit them from embracing the
approach. Concerns around lack of evidence on the cost
effectiveness of the model, lack of a legal and regulatory
framework, inequality in access to technology to patients and
care givers and need for common interoperability standards
may be other factors that are obstacles in the achievement of
a fully connected health care system [30].
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Overcoming these limitations for improving networking and
collaboration, it is critical to first identify outputs that are
mutually beneficial to all parties. Ensuring trust and
willingness to share expertise, data, rewards as well as risks
can add to the relationship and what could be achieved
through the collaboration [6]. Additionally, an open
collaborative approach in healthcare requires developing
clear structures for data protection; security and privacy
arrangements in place for sharing data from healthcare apps
with electronic health records. Patients’ involvement can be
elicited by giving them control of their data with
mechanisms in place to allow them to see who is using their
data and for what purposes. Similarly co-designing of
solutions with healthcare professionals, patients and care
givers can be harnessed by gathering evidences on the
economic benefit of their involvement [30]. State can
support crowd sourcing and crowd funding initiatives and
can address regulatory challenges by developing incentives
like open innovation credits, common IP frameworks and
public private partnerships that can facilitate the
development of an open collaborative healthcare ecosystem
[31].
An open model for practicing connected health is not just
about collaboration amongst multiple stakeholders across
disciplines and across levels but also about associations
beyond regions and nations [32]. It therefore requires
developing an open culture in organizations where working
with different players in the ecosystem is accepted and
endorsed. Procedures like cross functional networks beyond
borders are followed and skillsets are advanced for open
collaborative working [33]. By developing global policies
and creating open innovation-friendly markets and
regulatory conditions for cross border health services, the
concept may well be developed as a new open, inclusive,
multi-stakeholder, user-centric approach that can address the
contextual challenges of connected health services.
CONCLUSION
There is a need for the healthcare system to adapt to more
effective ways of developing networks and collaboration that
span beyond just R&D projects [11]. Open innovation, as
discussed above is a concept of vital interest in such a scenario.
It holds important synergies with the connected health approach
and thus can significantly impact the adoption of the approach
for sustainable networks and advanced outcomes in the
healthcare arena. This paper attempts to add to the process of
better understanding how an open interactive approach can
maximize the potential of the concept of connected health. We
categories healthcare firms into open innovation profiles, outline
examples of open innovation approaches adopted by
pharmaceutical firms, and propose an open innovation
framework for connected health. Undoubtedly, connected health
is a complex concept owing to its heterogeneity and more and
more future research needs to focus on exploring how the vital
concept can be integrated in the healthcare system to improve
and advance outcomes.
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